An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease
An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease
NCT ID: NCT05497765 Phase: NA Status: COMPLETED Enrollment: 94 Completion: 2024-02-20
Conditions
Nonalcoholic Fatty Liver Disease
Interventions
Silibinin extract, mixed power of pueraria, schisandra and salvia miltiorrhiza, Silibinin extract, Placebo
Summary
Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent liver disorder in China. The aim of this project is to evaluate the effects of compound silymarin on biomarkers of lipid metabolism and inflammation in the patients with NAFLD.
Primary Outcome
Liver enzymes